Biocompatibility and Regulatory Testing Services

The contract involves pre-market testing services for implantable medical devices, focusing on biocompatibility evaluations including cytotoxicity, sensitization, and irritation assessments, along with performance validation to ensure safety and functionality prior to regulatory submission. These tests are critical to meeting international standards for medical device approval and are conducted in a controlled, accredited environment to verify material compatibility with biological systems and device reliability under intended use conditions. The work is classified under NAICS code 541620, indicating it is a scientific and technical consulting service, and is structured as a subcontract under the Department of Veterans Affairs through the 261-NETWORK Contract Office 21. The requirement is posted for potential bidders as of August 8, 2026, with performance expected to align with federal regulatory expectations for implant devices, though specific geographic performance location and point of contact details are not provided. The scope implies a need for specialized laboratory expertise, comprehensive documentation, and adherence to quality systems supporting FDA or equivalent regulatory pathways.